Commonwealth Numbered Regulations

1984 No. 342 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 4

SCHEDULE 4
Regulation 6 AMENDMENTS OF SCHEDULE 5 TO THE NATIONAL HEALTH (PHARMACEUTICAL
BENEFITS) REGULATIONS
1. Omit item 25, substitute the following item:
          "25 Captropril                    With the written authority of the

Secretary-
Severe refractory hypertensive
disease
For the continuing treatment of
severe refractory cardiac failure
where treatment with captopril was
initiated in a hospital".
2. Omit item 31, substitute the following item:
          "31 Cephalothin Sodium, B.P.      Infections where positive

bacteriological evidence confirms
that cephalothin sodium is the
most appropriate therapeutic agent
Septicaemia, suspected or proven".
3. Omit item 32, substitute the following item:
          "32 Cephazolin Sodium             Infections where positive

bacteriological evidence confirms
that cephazolin sodium is the most
appropriate therapeutic agent
Septicaemia, suspected or proven".
4. Omit item 34, substitute the following item:

"34 Cephradine, B.P., for
          Injection                         Infections where positive

bacteriological evidence confirms
that cephradineis the most
appropriate therapeutic agent
Septicaemia, suspected or proven".
5. Omit item 58A.
6. Omit item 72A, substitute the following item:
          "72A Etretinate                   With the written authority of the

Secretary-
Treatment initiated in a hospital
of-
Darier's disease
Erythrokeratoderma
Pityriasis rubra pilaris
Severe congenital ichthyosis
(lamellar, bullous and sex linked)
Severe intractable psoriasis
Severe palmo-plantar keratoderma
For the continuing treatment of a
patient who has already received,
for more than 6 months, therapy
with etretinate for a condition
listed above".
7. Omit item 83.
8. Omit item 84, substitute the following item:

"84 Griseofulvin Tablets, B.
          P.                                Recalcitrant tinea infections

Kerion".
9. Omit item 114.
10. Omit item 117, substitute the following item:
          "117 Mexiletine Hydrochloride     Ventricular arrhythmias".

11. Omit item 118A, substitute the following item:
          "118A Minoxidil                   With the written authority of the

Secretary-
For the continuing treatment of
severe refractory hypertensive
disease wheretreatment with
minoxidil was initiated in a
hospital
For the continuing treatment of a
patient who has already received,
for more than 6 months, therapy
with minoxidil for severe
refractory hypertension".
12. Omit item 120A, substitute the following item:

"120A (1) Nalidixic Acid
          Mixture,     B.P.


(2) Nalidixic Acid Tablets,
              B.P.                          With the written authority of the

Secretary- For use as a urinary
antiseptic in patients with
neurogenic bladder
Urinary tract infections where
current clinical and
bacteriological evidence confirms
that nalidixic acid is the most
appropriate therapeutic agent".
13. Omit item 124, substitute the following item:
          "124 Nifedipine                   With the written authority of the

Secretary-
Angina".
14. After item 128 insert the following item:
          "128A 'ODORTROL'                  Ileostomy or colostomy
conditions".
15. Omit item 135, substitute the following item:

"135 (1) Penicillamine, B.P.

(2) Penicillamine Tablets,
               B.P.                         With the written authority of the

                                            Secretary-   Acute heavy metal

                                            intoxication   Cystinosis

Cystinuria with calculus
formation
For the continuing treatment of
rheuma- toid arthritis where
penicillamine therapy was
initiated in a hospital
Haemoglobinuria, paroxysmal cold
Patients with rheumatoid
arthritis who have already
received, for more than 6 months,
therapy with penicillamine
Wilson's disease
(hepatolenticular degeneration)".
16. Omit item 136.
17. Omit item 137, substitute the following item:
          "137 Perhexiline Maleate          With the written authority of the

Secretary-
Angina not responding to other
therapy".
18. Omit item 141A.
19. Omit item 180, substitute the following item:
          "180 Ticarcillin Sodium           With the written authority of the

Secretary-
Infections where positive
bacteriological evidence confirms
that ticarcillin sodium is the
most appropriate therapeutic agent
Septicaemia, suspected or
proven".
------------------------------------------------------------------------------
--